China SXT Pharmaceuticals (SXTC) Total Current Liabilities (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Total Current Liabilities of $4.3 million for Q1 2026, down 27.66% year-over-year from $6.0 million in Q1 2025, and down 27.04% quarter-over-quarter from $6.0 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Total Current Liabilities (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $4.3 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 27.66% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (down 27.66% YoY), while the FY2026 annual figure was $4.3 million, down 27.66% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $4.3 million, down from $6.0 million in the prior quarter.
- The five-year high for Total Current Liabilities was $17.1 million in Q1 2022, with the low at $4.3 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $8.9 million (2024), against an average of $9.9 million.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 70.26% in 2024, then plunged 61.94% in 2025.
- China SXT Pharmaceuticals' Total Current Liabilities stood at $7.3 million in 2022, then increased by 26.17% to $9.2 million in 2023, then jumped by 70.26% to $15.7 million in 2024, then slumped by 61.94% to $6.0 million in 2025, then decreased by 27.04% to $4.3 million in 2026.
- Business Quant data shows SXTC's Total Current Liabilities at $4.3 million in Q1 2026, $6.0 million in Q3 2025, and $6.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | China SXT Pharmaceuticals | 30,925.44 | -28.15 Mn | - | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.35 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Sep 30, 2024 | 15.66 Mn |
| Mar 31, 2024 | 8.90 Mn |
| Sep 30, 2023 | 9.20 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Sep 30, 2022 | 7.29 Mn |
| Mar 31, 2022 | 17.12 Mn |
| Sep 30, 2021 | 8.88 Mn |
| Mar 31, 2021 | 18.58 Mn |
| Sep 30, 2020 | 5.51 Mn |
| Mar 31, 2020 | 12.26 Mn |
| Sep 30, 2019 | 10.76 Mn |
| Mar 31, 2019 | 6.32 Mn |
| Sep 30, 2018 | 3.99 Mn |
| Mar 31, 2018 | 4.37 Mn |